The serious mental illness health improvement profile [HIP]: Study protocol for a cluster randomised controlled trial

Trials

Volumn 12, Issue , 2011, Pages

  White, Jacquie ^a,b   Gray, Richard J ^c   Swift, Louise ^c   Barton, Garry R ^b   Jones, Martin ^d  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT TOOL; CLINICAL PROTOCOL; COMMUNITY MENTAL HEALTH; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE DELIVERY; HEALTH IMPROVEMENT PROFILE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MENTAL HEALTH; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NURSE; NURSE ATTITUDE; NURSE PATIENT RELATIONSHIP; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT CARE PLANNING; PROFESSIONAL KNOWLEDGE; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SHORT FORM 2 HEALTH SURVEY; SINGLE BLIND PROCEDURE; WELLBEING; CLINICAL TRIAL; CLUSTER ANALYSIS; COMORBIDITY; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; HEALTH SERVICES RESEARCH; HEALTH STATUS; HOSPITALIZATION; INTEGRATED HEALTH CARE SYSTEM; MENTAL HEALTH SERVICE; METHODOLOGY; NATIONAL HEALTH SERVICE; NURSING; PATIENT CARE; PSYCHIATRIC NURSING; PSYCHOLOGICAL RATING SCALE; PSYCHOSIS; TIME; TREATMENT OUTCOME; UNITED KINGDOM;

BIPOLAR DISORDER; CLUSTER ANALYSIS; COMMUNITY MENTAL HEALTH SERVICES; COMORBIDITY; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE, INTEGRATED; ENGLAND; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HEALTH STATUS; HUMANS; MENTAL DISORDERS; PATIENT CARE TEAM; PSYCHIATRIC NURSING; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUALITY OF LIFE; RESEARCH DESIGN; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; STATE MEDICINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79959776443     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-167     Document Type: Article

References (56)

1. Department of Health Choosing Health: Supporting the physical needs of people with severe mental illness Commissioning Framework 2006, London: Department of Health, Department of Health.
2. Department of Health New Horizons, A shared vision for mental health 2009, London: Department of Health, Department of Health.
3. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease 2006, 3:1-14.
4. Roshanaei-Moghaddam B, Katon W. Premature Mortality From General Medical Illnesses Among Persons With Bipolar Disorder: A Review. Psychiatric Services 2009, 60:147-156. 10.1176/appi.ps.60.2.147, 19176408.
5. Nasrallah HA, Meyer JM, Goff DC, McEvoy JP, Davis B, Stroup S, Lieberman JA. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Research 2006, 86:15-22. 10.1016/j.schres.2006.06.026, 16884895.
6. McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, Meltzer HY, Hsiao J, Stroup S, Lieberman JA. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research 2005, 80:19-32. 10.1016/j.schres.2005.07.014, 16137860.
7. Haddad P. Weight change with atypical antipsychotics in the treatment of schizophrenia. Journal of Psychopharmacology 2005, 19(6 Suppl):s16-s27.
8. Robson D, Gray R. Serious mental illness and physical health problems: a discussion paper. International Journal of Nursing Studies 2007, 44:457-466. 10.1016/j.ijnurstu.2006.07.013, 17007859.
9. Shahzad S, Suleman MI, Shahab H, Mazour I, Kaur A, Rudzinskiy P, Lippmann S. Cataract Occurrence With Antipsychotic Drugs. Psychosomatics 2002, 43(5):354-359. 10.1176/appi.psy.43.5.354, 12297603.
10. Halbreich U, Kahn LS. Hyperprolactinemia and schizophrenia: mechanisms and clinical aspects. Journal of Psychiatric Practice 2003, 9:344-351. 10.1097/00131746-200309000-00003, 15985953.
11. Freidlander AH, Marder SR. The psychopathology, medical management and dental implications of schizophrenia. Journal of the American Dental Association 2002, 133:603-610.
12. Gournay K. Setting clinical standards for care on schizophrenia. Nursing Times 1996, 92:36-37.
13. Phelan M, Stradins L, Morrison S. Physical health of people with severe mental illness. BMJ 2001, 322:443-444. 10.1136/bmj.322.7284.443, 1119672, 11222406.
14. Disability Rights Commission Equal Treatment:Closing the Gap 2006, London: Disability Rights Commission, Disability Rights Commission.
15. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT, Friedman A, Kleinberg D, Yevich SJ, Davis B, Shon S. Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry 2004, 161:1334-1349. 10.1176/appi.ajp.161.8.1334, 15285957.
16. National Institute of Health and Clinical Excellence Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care NICE clinical guideline 1 2002, London: NICE, National Institute of Health and Clinical Excellence.
17. National Institute of Health and Clinical Excellence The management of bipolar disorder in adults, children and adolescents, in primary and secondary care NICE clinical guideline 38 2006, London: NICE, National Institute of Health and Clinical Excellence.
18. National Institute of Health and Clinical Excellence Core interventions in the treatment and management of schizophrenia in primary and secondary care (update) 2009, London: NICE, National Institute of Health and Clinical Excellence.
19. Tosh G, Clifton A, Mala S, Bachner M. Physical health care monitoring for people with serious mental illness. Cochrane Database Syst Rev 2010, 17(3):CD008298.
20. Burns T, Cohen A. Item of service payments for general practitioner care of severely mentally ill persons: does the money matter?. British Journal of General Practice 1998, 48(432):1415-6. 1313136, 9800401.
21. Paton C, Esop R, Young C, Taylor D. Obesity, dyslipidaemias and smoking in an in-patient population treated with antipsychotic drugs. Acta Psychiatrica Scandinavica 2004, 110:299-305. 10.1111/j.1600-0447.2004.00372.x, 15352932.
22. Barnes TRE, Paton C, Hancock E, Cavanagh MT, Taylor D, Lelliott P, . on behalf of the UK Prescribing Observatory for Mental Health Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme. Acta Psychiatrica Scandinavica 2008, 118(1):26-33. 10.1111/j.1600-0447.2008.01203.x, 18582345, on behalf of the UK Prescribing Observatory for Mental Health.
23. Healthcare Commission No Voice, No Choice: A joint review of adult community mental health services in England 2007, London: Healthcare Commission, Healthcare Commission.
24. Eldridge D, Dawber N, Gray R. A well-being support program for patients with severe mental illness: a service evaluation. BMC Psychiatry 2011, 11:46. 10.1186/1471-244X-11-46, 3070634, 21418627.
25. Department of Health From Values to Action: The Chief Nursing Officer's review of mental health nursing 2006, London: Department of Health, Department of Health.
26. Nash M. Physical care skills: a training needs analysis of inpatient and community mental health nurses. Mental Health Practice 2005, 9(4):20-3.
27. Gray R, Wykes T, Gournay K. The effect of medication management training on community mental health nurse's clinical skills. International Journal of Nursing Studies 2003, 40:163-169. 10.1016/S0020-7489(02)00045-7, 12559140.
28. Gray R, Wykes T, Edmonds M, Leese M, Gournay K. Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia: Cluster randomised controlled trial. British Journal of Psychiatry 2004, 185:157-162. 10.1192/bjp.185.2.157, 15286068.
29. Jordan S, Tunnicliffe C, Sykes A. Minimizing side-effects: the clinical impact of nurse-administered 'side-effect' checklists. Journal of Advanced Nursing 2002, 37:155-165. 10.1046/j.1365-2648.2002.02064.x, 11851783.
30. Morrison P, Meehan T, Gaskill D, Lunney P, Collings P. Enhancing case managers' skills in the assessment and management of antipsychotic medication side-effects. Australian and New Zealand Journal of Psychiatry 2000, 34:814-821.
31. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. British Medical Journal 2008, 336(7659):1475-1482. 10.1136/bmj.39609.449676.25, 2440904, 18573856.
32. Shuel F, White J, Jones M, Gray R. Using the serious mental illness health improvement profile [HIP] to identify physical problems in a cohort of community patients: A pragmatic case series evaluation. International Journal of Nursing Studies 2010, 47(2):136-145. 10.1016/j.ijnurstu.2009.06.003, 19596322.
33. Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. BMJ 2004, 328:702-708. 10.1136/bmj.328.7441.702, 381234, 15031246.
34. Ware JE. User's manual for the SF36v2 health survey - second edition 2007, Lincoln RI: Quality Metric Inc.
35. Ware JE. SF-36 Health Survey Update. The Use of Psychological testing For Treatment Planning and Outcomes Assessment 2004, 3:693-718. Lawrence Erlbaum Associates, Maruish ME, Mahwah NJ, Third.
36. Russo J, Trujillo CA, Wingerson D, Decker K, Ries R, Wetzler H, Roy-Byrne P. The MOS 36-Item Short Form Health Survey: Reliability, Validity, and Preliminary Findings in Schizophrenia Outpatients. Medical Care 1998, 36:752-756. 10.1097/00005650-199805000-00015, 9596066.
37. Barton GR, Hodgekins J, Mugford M, Jones PB, Croudace T, Fowler D. Cognitive behaviour therapy for improving social recovery in psychosis: Cost-effectiveness analysis. Schizophrenia Research 2009, 112:158-163. 10.1016/j.schres.2009.03.041, 19403270.
38. Chisholm D, Knapp MRJ, Knudsen HC, Amaddeo F, Gaite L, Van Wijngaarden B. Client Socio-Demographic and Services Receipt Inventory-European Version: development of an instrument for international research EPSILON Study 5. British Journal of Psychiatry 2000, 177:s28-s33.
39. The EuroQol Group EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. The EuroQol Group.
40. Robson D, Haddad M. Mental Health Nurse Physical Health Attitude Scale [PHASe]. 2010, Institute of Psychiatry, Kings College London, King's Health Partners.
41. QRISK® 2010 Annual Release 2010 Documentation. , http://www.qrisk.org/QRISK2%202010%20Annual%20Update%20Information.pdf
42. Norfolk and Waveney Mental Health NHS Foundation Trust Consent to Examination and Treatment Policy C71: Version 2 2005, Norfolk: NWMHFT, Norfolk and Waveney Mental Health NHS Foundation Trust.
43. White J, Gray R, Jones M. The development of the serious mental illness physical Health Improvement Profile. Journal of Psychiatric and Mental Health Nursing 2009, 16:493-498. 10.1111/j.1365-2850.2009.01375.x, 19538607.
44. Schulz KF, Altman DG, Moher D, . CONSORT Group CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. Trials 2010, 11:32. 10.1186/1745-6215-11-32, 2857832, 20334632, CONSORT Group.
45. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, Elbourne D, Egger M, Alman DG. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c869. 10.1136/bmj.c869, 2844943, 20332511.
46. Guest G, Bunce A, Johnson L. How Many Interviews are Enough? An Experiment with Data Saturation and Variability. Field Methods 2006, 18:59-82.
47. National Institute of Health and Clinical Excellence Guide to the Methods of Technology Appraisal 2008, London: NICE, National Institute of Health and Clinical Excellence.
48. Brooks R. EuroQol: the current state of play. Health Policy 1996, 37:53-72. 10.1016/0168-8510(96)00822-6, 10158943.
49. Barton GR, Briggs AH, Fenwick EA. Optimal cost-effectiveness decisions: The role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). Value in Health 2008, 11(5):886-897. 10.1111/j.1524-4733.2008.00358.x, 18489513.
50. Braun V, Clark V. Using Thematic Analysis in psychology. Qualitative Research in Psychology 2006, 3:77-101.
51. Lincoln YS, Guba EG. Naturalistic Enquiry 1985, Newbury Park CA: Sage.
52. Nash M. Assessing nurses' propositional knowledge of physical health. Mental Health Practice 2010, 14:20-23.
53. Osborn D, Nazareth I, Wright C, King M. Impact of a nurse-led intervention to improve screening for cardiovascular risk factors in people with severe mental illnesses. Phase-two cluster randomised feasibility trial of community mental health teams. BMC Health Services Research 2010, 10:61. 10.1186/1472-6963-10-61, 2850904, 20219096.
54. Smith S, Yeomans D, Bushe CJP, Eriksson C, Harrison T, Holmes R, Mynors-Wallis L, Oatway H, Sullivan G. A well-being programme in severe mental illness. Baseline findings in a UK cohort. International Journal of Clinical Practice 2007, 61:1971-1978. 10.1111/j.1742-1241.2007.01605.x, 2779991, 17997803.
55. Smith S, Yeomans D, Bushe CJP, Eriksson C, Harrison T, Holmes R, Mynors-Wallis L, Oatway H, Sullivan G. A well-being programme in severe mental illness. Reducing risk for physical ill-health: A post-programme service evaluation at 2 years. European Psychiatry 2007, 22(7):413-418. 10.1016/j.eurpsy.2007.07.002, 17765483.
56. Council MR. Developing and evaluating complex interventions: new guidance. 2009, Medical Research Council.